Skip to content
Explore cutting-edge solar energy technology, sustainable s…

Zimbabwe Rejects ‘Lopsided’ US Health Aid Deal Because of Data Apprehensions

Health aid image
The offered American funding would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has turned down a major American health deal worth 367 million US dollars (272 million pounds) over five years over Washington's request for sensitive information.

The decision came to light after a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".

An official spokesman has since explained that the United States was seeking health data for scientific study and commercial purposes but was unwilling to share the resulting advantages from future medical innovations.

"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has urged more dialogue to reach a deal agreeable to both sides so the country's vital HIV programme can be sustained.

Wider Context

This rejection comes after a comparable case in neighbouring Kenya, where a high court blocked a related deal with the US following concerns were raised about the security of Kenyans' health data.

After returning to office last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).

The agency had managed aid for the American government, but Trump claimed its spending was "wasteful" and his administration was pursuing direct bilateral agreements to enhance openness and accountability.

Based on reports, 16 African countries have to date agreed to these new health pacts, representing over $18.3bn of fresh investment.

Details of the Rejected Deal

The money for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".

"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.

"Put simply, our nation would supply the basic resources for medical research with no assurance that the resulting innovations would be available to our citizens should a new pandemic emerge."

National Interest and International Frameworks

He also noted that the American exit from the global health body and its push of bilateral health agreements were upending frameworks already set up through the global health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.

"This system is designed to ensure that when a nation provides its data, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to create them."

These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.

"We encourage ongoing discussions with our American counterparts on how future collaboration could be designed in a way that respects the independence and interests of both nations."

Medical Community Response

Medical experts stated it acknowledged the official position, but recommended that talks need to persist since much of the country's HIV programmes were funded by external financing.

"If specific concerns arise, such as those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.

The halted deal highlights the ongoing tensions between accepting crucial foreign assistance and protecting a country's data in an ever more data-driven world.

MW
By

Michael Woods

Renewable energy expert with 10+ years in solar technology development and sustainable innovation advocacy.

Solar Cards Platform

Type to search articles.